NCT07765953

Brief Summary

This prospective observational cohort study evaluated temporal trends in primary aesthetic breast augmentation, breast implant replacement, and definitive breast implant removal at IQ Interquirofanos in Medellín, Colombia. Clinical and surgical information was prospectively collected at the time of surgery in an institutional registry from January 1, 2012, through December 31, 2024. The cohort included 22,642 unique adult participants, each of whom contributed one eligible surgical event and was classified into one of three mutually exclusive groups: primary implant placement, implant replacement, or implant removal. The primary outcome was the annual and overall distribution of these procedure categories. Secondary outcomes included breast implant volume, duration of prior implant use, indications for replacement and removal, and the relationships between participant age, implant volume, and implant duration. Surgical procedures were selected as part of routine clinical care and were not assigned by the investigators for research purposes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22,642

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
13 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

August 10, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 14, 2026

Completed
Last Updated

August 14, 2026

Status Verified

August 1, 2026

Enrollment Period

13 years

First QC Date

August 10, 2026

Last Update Submit

August 10, 2026

Conditions

Keywords

Breast augmentationBreast implantsImplant replacementBreast implant removalExplantationAesthetic breast surgeryTemporal trendsProspective observational cohort

Outcome Measures

Primary Outcomes (1)

  • Annual and Overall Distribution of Aesthetic Breast Implant Procedure Categories

    the number and percentage of eligible participants undergoing primary implant placement, implant replacement, or implant removal will be calculated for each calendar year. The numerator is the number of participants in each procedure category, and the denominator is the total number of eligible participants undergoing one of the three procedures during the corresponding calendar year. Overall counts and percentages will also be calculated across the complete observation interval. Each participant contributes one mutually exclusive surgical event.

    yearly, each year the eligible surgical event; reported separately for calendar years 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, and 2024

Secondary Outcomes (4)

  • Right- and Left-Sided Breast Implant Volume by Calendar Year and Procedure Group

    yearly, At the eligible surgical event; reported separately for calendar years 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, and 2024

  • Duration of Prior Breast Implant Use at Replacement or Removal

    At the breast implant replacement or removal surgical event; eligible events occurring from January 1, 2012, through December 31, 2024. we looked for events yearly, it could be 0 years up to 15 years

  • Distribution of Recorded Indications for Breast Implant Replacement

    At the breast implant replacement surgical event; reported separately for calendar years 2012 through 2024. Yearly

  • Distribution of Recorded Indications for Definitive Breast Implant Removal

    At the definitive breast implant removal surgical event; reported separately for calendar years 2012 through 2024. Yearly

Study Arms (1)

Aesthetic Breast Implant Placement

Adult participants undergoing primary aesthetic breast surgery, removal of previously placed breast implants followed by placement of new breast implants or removal without placement of breast implants.

Procedure: Primary Aesthetic Breast AugmentationProcedure: Breast Implant ReplacementProcedure: Definitive Breast Implant Removal

Interventions

Placement of breast implants for aesthetic augmentation as part of routine clinical care. The procedure was not assigned by the investigators.

Aesthetic Breast Implant Placement

Removal of previously placed breast implants followed by placement of new breast implants as part of routine clinical care. The procedure was not assigned by the investigators.

Aesthetic Breast Implant Placement

Removal of previously placed breast implants without placement of replacement implants. The procedure was selected during routine clinical care and was not assigned by the investigators.

Aesthetic Breast Implant Placement

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult participants undergoing primary aesthetic breast implant placement, breast implant replacement, or definitive breast implant removal at IQ Interquirofanos in Medellín, Colombia, between January 1, 2012, and December 31, 2024. Each participant contributed one unique surgical event.

You may qualify if:

  • Participants aged 18 years or older. Participants undergoing primary aesthetic breast implant placement, breast implant replacement, or definitive breast implant removal.
  • Procedure performed at IQ Interquirofanos. Complete clinical and surgical records for the eligible procedure. Documented postoperative follow-up in the institutional record.

You may not qualify if:

  • Breast surgery performed for reconstructive indications, including postmastectomy reconstruction, congenital deformity, or trauma.
  • Mixed reconstructive and aesthetic indications. Missing core clinical or surgical variables. Absence of documented postoperative follow-up.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IQ interquirofanos

Medellín, Antioquia, 050022, Colombia

Location

Related Publications (5)

  • Lieffering AS, Hommes JE, Ramerman L, Rakhorst HA, Mureau MAM, Verheij RA, van der Hulst RRWJ. Prevalence of Local Postoperative Complications and Breast Implant Illness in Women With Breast Implants. JAMA Netw Open. 2022 Oct 3;5(10):e2236519. doi: 10.1001/jamanetworkopen.2022.36519.

    PMID: 36205992BACKGROUND
  • Ramalho AAL, Tavares AA, da Silva HN, Navarro RF, da Silva VAVC, Melchior SC, Vicente MG, Fook MVL, Silva SML. Safety and Performance of Postmarketing Breast Implants: An Integrated Review with Technovigilance Data. J Clin Med. 2025 Jun 12;14(12):4164. doi: 10.3390/jcm14124164.

    PMID: 40565910BACKGROUND
  • Zhang Z, Qi J, Zhang X, Wang J, Li Z, Xin M. What Can We Learn from Breast Implant Explantation: a 28-Year, Multicenter Retrospective Study of 1004 Explantation Cases. Aesthetic Plast Surg. 2023 Oct;47(5):1743-1750. doi: 10.1007/s00266-023-03365-4. Epub 2023 May 18.

    PMID: 37204467BACKGROUND
  • Chen Z, Sun Y, Weng H, Tong J, Yang J, Wang R, Sun J. A Long-Term Single-Center Study: Motivations and Strategies in Implant Management for Breast Augmentation Revision Surgery. Aesthetic Plast Surg. 2025 Dec;49(23):6543-6552. doi: 10.1007/s00266-025-05049-7. Epub 2025 Jul 16.

    PMID: 40670655BACKGROUND
  • Calobrace MB, Schwartz MR, Kaufman DL, Gordon AE, Cohen R, Harrington J, Dajles D, Zeidler K. Safety and Efficacy of the Sientra Silicone Gel Round and Shaped Breast Implants: 6-Year Results of the U.S. Postapproval Study. Plast Reconstr Surg. 2024 Jul 1;154(1):44e-56e. doi: 10.1097/PRS.0000000000010953. Epub 2023 Aug 11.

    PMID: 37563756BACKGROUND

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
INDUSTRY
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, Aerospace medicine, MSc, PhD(c)

Study Record Dates

First Submitted

August 10, 2026

First Posted

August 14, 2026

Study Start

January 1, 2012

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

August 14, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Locations